Genpact Limited
G
$36.40
$1.755.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.25B | 5.16B | 5.08B | 5.01B | 4.93B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.25B | 5.16B | 5.08B | 5.01B | 4.93B |
| Cost of Revenue | 3.34B | 3.29B | 3.25B | 3.21B | 3.17B |
| Gross Profit | 1.91B | 1.87B | 1.83B | 1.79B | 1.76B |
| SG&A Expenses | 1.10B | 1.08B | 1.05B | 1.02B | 999.17M |
| Depreciation & Amortization | 22.05M | 23.08M | 24.29M | 23.42M | 21.63M |
| Other Operating Expenses | -508.00K | -532.00K | -280.00K | -321.00K | -233.00K |
| Total Operating Expenses | 4.46B | 4.39B | 4.32B | 4.25B | 4.19B |
| Operating Income | 791.16M | 775.75M | 760.57M | 755.59M | 735.71M |
| Income Before Tax | 763.06M | 748.92M | 730.15M | 723.86M | 710.00M |
| Income Tax Expenses | 180.41M | 179.29M | 177.65M | 172.55M | 171.69M |
| Earnings from Continuing Operations | 582.65 | 569.63 | 552.49 | 551.32 | 538.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 582.65M | 569.63M | 552.49M | 551.32M | 538.30M |
| EBIT | 791.16M | 775.75M | 760.57M | 755.59M | 735.71M |
| EBITDA | 883.19M | 868.43M | 853.48M | 846.79M | 824.53M |
| EPS Basic | 3.40 | 3.30 | 3.18 | 3.15 | 3.06 |
| Normalized Basic EPS | 2.82 | 2.75 | 2.67 | 2.62 | 2.53 |
| EPS Diluted | 3.37 | 3.26 | 3.13 | 3.10 | 3.01 |
| Normalized Diluted EPS | 2.78 | 2.71 | 2.62 | 2.58 | 2.49 |
| Average Basic Shares Outstanding | 684.81M | 690.35M | 695.57M | 699.60M | 703.62M |
| Average Diluted Shares Outstanding | 694.37M | 701.00M | 706.59M | 710.78M | 714.39M |
| Dividend Per Share | 0.72 | 0.70 | 0.68 | 0.66 | 0.65 |
| Payout Ratio | 20.88% | 21.02% | 21.31% | 20.93% | 21.00% |